SCOOP: Calif. officials acknowledge testing gaps in lab suit
In a March hearing, California Department of Cannabis Control experts testified to gaps in agency practices which could affect testing results for contaminants.
The March hearing stemmed from the 2025 closure of BelCosta Labs which owed at least in part to positive tests for the mold aspergillus. The lab had operated on a provisional license since 2018 when the California REC market opened.
- Questioning of the DCC experts was conducted by BelCosta CEO Myron Ronay, a licensed, non-practicing lawyer.
According to a summary prepared by Ronay . . .
Log in or become a WeedWeek Member to read this article.
